About The Longevity Fund
Seed and Series A investor—the first specialist fund focused solely on treating aging as a disease—led by Laura Deming; portfolio companies have raised >$1B and produced multiple IPOs.
The Longevity Fund
United States$100K – $1M
Similar investors
.406 Ventures Fund
United States
Selective firm investing where it has an unfair advantage, running a company-creation platform with 22 EIRs and a 90+ C-suite council delivering market insights to healthcare, data+AI and cybersecurity.
Series ASeries BTechnologyHealthcare
$2M – $5M
1955 Capital
United States
Targets hard, capital‑intensive sustainability technologies other VCs avoid, bridging solutions from developed markets into China and developing countries (energy, food, health, environment) to build traction back into developed markets.
Series ASeries BAgricultureEducation
$5M – $10M
25M Health
United States
Venture studio and fund that co‑incubates with LifePoint executives, giving startups direct access to a $50B+ health system for pilot deployment, real‑world validation, and underserved population focus.
Series ASeries BPre-SeedRetailTechnology
$500K – $1M
3CC | Third Culture Capital
United States
Physician-led, immigrant-founded VC built by third-culture founders using cross-cultural insight to back healthcare founders with lived experience and target structural health inequities over generic digital tools.
Series APre-SeedTechnologyHealthcare
$250K – $1M
4DX Ventures
Africa
NY headquarters plus offices in Accra, Cairo and Nairobi combine global capital-market access with local operator proximity; ex-Bridgewater/Morgan Stanley founders and repeat backer of Africa's B2B e-commerce leaders.
Series APre-SeedAgricultureFinance
$50K – $500K
7wire Ventures
United States
Focuses on companies empowering informed, connected health consumers and building system-level resilience to improve outcomes, experiences, and lower healthcare costs.
Series ASeries BTechnologyHealthcare
$100K – $5M